- Advertisement -
Proteomics International Laboratories testing using its “PromarkerD” device that employs a simple finger-prick blood test has shown a high accuracy in being able to predict future kidney disease in type 1 diabetes patients.
The company has told this week’s Australasian Diabetes Conference…
